Evidence map›Paper›PMID 41331018›Full record

ArticleScientific reports2025

pCPPs-sADNN: predicting cell-penetrating peptides using self-attention based deep neural network.

Naif Almusallam, Shahid, Maqsood Hayat, Fawaz Khaled Alarfaj

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. INBAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Naif Almusallam2Department of Management Information Systems, School of Business, King Faisal University, Al Ahsa, 31982, Saudi Arabia.
Shahid1Department of Computer Science, Abdul Wali Khan University Mardan, Mardan, KP, Pakistan.
Maqsood Hayat1Department of Computer Science, Abdul Wali Khan University Mardan, Mardan, KP, Pakistan. m.hayat@awkum.edu.pk.
Fawaz Khaled Alarfaj2Department of Management Information Systems, School of Business, King Faisal University, Al Ahsa, 31982, Saudi Arabia.

Funding

Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia KFU253807
6 · The paper itself

Abstract

Cell-penetrating peptides (CPPs) are short peptides consisting of 5 to 50 amino acids and useful for drug delivery and intracellular localization. Laboratory-based techniques are often lengthy and resource-intensive, whereas computational approaches offer a rapid and cost-effective solution. To address these limitations, this research introduces a predictive model called pCPPs-sADNN leveraging feature fusion, integrating embeddings from the protein pre-trained language models Protein Text-to-Text Transfer Transformer and Evolutionary Scale Modeling, along with Conjoint Triad Features. By combining the distinct derived feature sets, generates an enhanced and robust features vector. Furthermore, we employed Random Forest-based Recursive Feature Elimination for feature selection and used the Adaptive Synthetic Sampling Approach to address class imbalance by generating synthetic minority samples. The hybrid feature set was subsequently utilized to train a deep neural network enhanced with an attention mechanism. The proposed pCPPs-sADNN model achieved a high training accuracy of 98.58% and an AUC of 0.99. In evaluation on test dataset, pCPPs-sADNN demonstrated strong performance with an accuracy of 96.84% and an AUC of 0.99.

Indexed as

Cell-Penetrating PeptidesComputational BiologyNeural Networks, ComputerAlgorithmsDeep LearningHumansCell-Penetrating Peptides

Identifiers

PMID41331018
PMCPMC12783794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.